Home | Business News | Browse by Publication | P | Pharmaceutical Technology Europe

Transatlantic integration a necessity.

Publication: Pharmaceutical Technology Europe
Publication Date: 01-JUL-09 		Format: Online
Delivery: Immediate Online Access

Article Excerpt
The current global diversity of drug approval processes is negatively impacting drug launches, which is why Frost & Sullivan believes there is a "pressing need" for the integration of the US and EU regulatory environments. "The future of the pharmaceutical industry lies in the globalization of drug approval processes," said Sylvia Findlay, Programme Leader at Frost & Sullivan.

Speaking exclusively to Pharmaceutical Technology Europe (PTE), Findlay explained that approval...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.